QIAseq Targeted DNA panels
Solutions to reach unprecedented insights in oncology research
The level of Tumor Mutational Burden (TMB) and Microsatellite Instability Status (MSI) can be indicators of response to immuno-oncology therapies. Researchers need integrated and reliable tools to get the most information out of their samples to gain novel insights into cancer treatment. Discover solutions that can propel your research forward, from Sample to Insight.
For purification of genomic DNA from formalin-fixed paraffin-embedded tissues
Show details
See products
For simultaneous purification of genomic DNA and total RNA (including small RNAs) from formalin-fixed, paraffin-embedded tissue sections
Show details
See products
Show all products
For creating a comprehensive profile of Tumor Mutational Burden (TMB) and Microsatellite Instability Status (MSI)
Show details
See products
Digital DNA sequencing to confidently detect low-frequency variants
Show details
See products
For indexing samples enriched with either QIAseq Targeted DNA Panels or QIAseq Targeted RNAscan Panels
Show details
See products
Show all products
Show all products
For analyzing and interpreting real-time PCR or NGS data
Show details
See products
QCI Analyze offers all the tools you need to guide your NGS data analysis.
Show details
See products
Show all products
Le site web n’est pas disponible en français dans son intégralité. Son contenu est international et peut aller à l’encontre des règlementations locales.